Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net loss	$ (381,574,958)	$ (20,706,448)	$ (478,170)
Adjustment to reconcile net loss to net cash from operating activities:
Depreciation	831,715	2,009	0
Loss on sale of asset	238,917	0	0
Deferred income tax benefit	(28,551,379)	0	0
Issuance of warrants for advisory fees	15,646,280	16,600,500	0
Other stock based compensation	7,129,316	435,000	0
Amortization of intangible assets	9,797,226	0	0
Impairment of goodwill	144,357,493	0	0
Derivative fair value adjustment	585,584	0	0
Fair value in excess of financing proceeds	29,215,500	0	0
Warrant fair value adjustment	109,396,720	0	0
Inventory writedowns	11,200,000	0
Bad debts	(2,093,205)	0	0
Loss on conversion of notes	1,066,083	0	0
Loss on extinguishment of debt	5,643,735	0	0
Common stock issued for professional services	135,000	0	0
Amortization of debt discount	29,210,429	1,451,621
Amortization of deferred financing costs	3,012,046	210,020	0
Changes in operating assets and liabilities:
Accounts receivable	(1,916,701)	44,374	(156,977)
Inventory	4,136,676	(53,263)	(241,177)
Other prepaid expenses, deposit, advances	(3,031,630)	107,967	(119,588)
Other current assets	(11,606)	(6,750)	0
Accounts payable and accrued expenses	10,098,080	258,347	37,695
Deferred revenue	0	(17,699)	17,699
Other liabilities	1,058,811	20,000	0
Deferred compensation	0	(350,003)	350,003
Net cash used in operating activities	(29,733,458)	(2,004,325)	(590,515)
Cash flows from investing activities:
Purchases of property and equipment	(1,297,536)	(29,385)	0
Acquisition of businesses, net of cash acquired	(26,146,865)	0	0
Net cash used in investing activities	(27,444,401)	(29,385)	0
Cash flows from financing activities:
Revolving line of credit, net	(11,290,086)	(20,641)	20,641
Proceeds from issuance of debt	68,495,000	198,379	0
Payments on convertible notes	(450,000)	0	0
Payments on debt	(31,783,052)	(1,200,000)	0
Proceeds from issuance of common stock	30,551,031	4,486,221	0
Deferred financing and offering costs	(3,012,046)	(210,020)	0
Proceeds from exercise of stock options and warrants	137,550	0	0
(Repayments) advances from related party, net	(448,166)	844,296	580,953
Net cash provided by financing activities	52,200,231	4,098,235	601,594
Effect of exchange rate changes on cash	4,995,140	0	0
Net change in cash	17,512	2,064,525	11,079
Cash at beginning of the year	2,081,963	17,438	6,359
Cash at end of the year	2,099,475	2,081,963	17,438
Supplementary Cash Flow Information
Cash paid for Interest	45,078,330	368,028	23
Disclosures of Non-Cash Investing and Financing Activities
Derivatives in financing transactions	62,868,237	0	0
Exercise of warrants	4,248,688	0	0
Financing of building acquisition	430,572	0	0
Conversion of convertible promissory notes	$ 200,000	$ 0	$ 0
Stock issued in reverse merger	0	10,844	0
Convertible debenture assumed as part of reverse merger	0	210,000	0
Retirement of shares returned from shareholder	0	1,600	0